Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Thiazolidinediones: the Forgotten Diabetes Medications
Harold E. Lebovitz
Current Diabetes Reports (2019) Vol. 19, Iss. 12
Open Access | Times Cited: 295

Showing 26-50 of 295 citing articles:

Plant Extracts for Type 2 Diabetes: From Traditional Medicine to Modern Drug Discovery
Jinjoo Lee, Seungjin Noh, Suhyun Lim, et al.
Antioxidants (2021) Vol. 10, Iss. 1, pp. 81-81
Open Access | Times Cited: 68
Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK/ERK signaling
Yi Liu, Jingan Chen, Haowei Liang, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 68
The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms
Elena Massimino, Anna Izzo, Gabriele Riccardi, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1958-1958
Open Access | Times Cited: 62
Cancer and diabetes: the interlinking metabolic pathways and repurposing actions of antidiabetic drugs
Ahmed Olatunde, Manisha Nigam, Rahul Singh, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 60
Youth-onset type 2 diabetes mellitus: an urgent challenge
Petter Bjornstad, Lily C. Chao, Melanie Cree‐Green, et al.
Nature Reviews Nephrology (2022) Vol. 19, Iss. 3, pp. 168-184
Open Access | Times Cited: 58
Inflammatory Mechanisms of Diabetes and Its Vascular Complications
Lyudmila Viktorovna Nedosugova, Yuliya V. Markina, Л. А. Бочкарева, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1168-1168
Open Access | Times Cited: 49
4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design
Piotr Roszczenko, Serhii Holota, Olga Szewczyk‐Roszczenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13135-13135
Open Access | Times Cited: 46
Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches
Peng-Fei Ding, Huasheng Zhang, Jie Wang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 45
The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 35
Current Clinical Trial Status and Future Prospects of PPAR-Targeted Drugs for Treating Nonalcoholic Fatty Liver Disease
S Kamata, Akihiro Honda, Isao Ishii
Biomolecules (2023) Vol. 13, Iss. 8, pp. 1264-1264
Open Access | Times Cited: 35
Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
Eugenia Piragine, Davide Petri, Alma Martelli, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 1981-1981
Open Access | Times Cited: 33
Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19
Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, et al.
Science Immunology (2023) Vol. 8, Iss. 82
Open Access | Times Cited: 25
Achyranthes bidentata polysaccharide ameliorates type 2 diabetes mellitus by gut microbiota-derived short-chain fatty acids-induced activation of the GLP-1/GLP-1R/cAMP/PKA/CREB/INS pathway
Ting Xia, Wen He, Zhen‐Ye Luo, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132256-132256
Closed Access | Times Cited: 15
Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches
Tatjana Radosavljević, Milica Branković, Janko Samardžić, et al.
Antioxidants (2024) Vol. 13, Iss. 8, pp. 906-906
Open Access | Times Cited: 14
New-Generation Glucokinase Activators: Potential Game-Changers in Type 2 Diabetes Treatment
Dania Haddad, Vanessa Sybil Dsouza, Fahd Al‐Mulla, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 571-571
Open Access | Times Cited: 12
Pathophysiology and Advances in the Therapy of Cardiomyopathy in Patients with Diabetes Mellitus
Patryk Graczyk, Aleksandra Dach, Kamil Dyrka, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 5027-5027
Open Access | Times Cited: 11
Heme oxygenase, biliverdin reductase, and bilirubin pathways regulate oxidative stress and insulin resistance: a focus on diabetes and therapeutics
Wang‐Hsin Lee, Zachary A. Kipp, Sally Pauss, et al.
Clinical Science (2025) Vol. 139, Iss. 02, pp. 171-198
Open Access | Times Cited: 1
Pharmacological Profile of NCP-322, a Novel G Protein-Coupled Receptor 119 Agonist, as an Orally Active Therapeutic Agent for Type 2 Diabetes Mellitus
Hideki Nakamura, Tsuyoshi Endo, Makoto Tsuda
Biological and Pharmaceutical Bulletin (2025) Vol. 48, Iss. 1, pp. 65-74
Open Access | Times Cited: 1
Linking Cardiovascular Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Role of Cardiometabolic Drugs in MASLD Treatment
Marios Zisis, Maria Chondrogianni, Θεόδωρος Ανδρουτσάκος, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 324-324
Open Access | Times Cited: 1
A randomised, double-blind, placebo-controlled, multi-centre, dose-range, proof-of-concept, 24-week treatment study of lanifibranor in adult subjects with non-alcoholic steatohepatitis: Design of the NATIVE study
Francque Sven M., Bedossa Pierre, Abdelmalek Manal F., et al.
Contemporary Clinical Trials (2020) Vol. 98, pp. 106170-106170
Open Access | Times Cited: 60
Pioglitazone Inhibits Diabetes-Induced Atrial Mitochondrial Oxidative Stress and Improves Mitochondrial Biogenesis, Dynamics, and Function Through the PPAR-γ/PGC-1α Signaling Pathway
Zhiwei Zhang, Xiaowei Zhang, Lei Meng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 53
Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
Jaehyun Bae, Taegyun Park, Hyeyoung Kim, et al.
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 3, pp. 326-336
Open Access | Times Cited: 41
The management of diabetes mellitus by mangiferin: advances and prospects
Mengdi Wang, Yan Liang, Keqi Chen, et al.
Nanoscale (2021) Vol. 14, Iss. 6, pp. 2119-2135
Closed Access | Times Cited: 41
Diabetes and Impaired Fracture Healing: A Narrative Review of Recent Literature
Mina Tanios, Bradley Brickman, Emily Cage, et al.
Current Osteoporosis Reports (2022) Vol. 20, Iss. 5, pp. 229-239
Closed Access | Times Cited: 34
The Role of Transcription Factor PPAR-γ in the Pathogenesis of Psoriasis, Skin Cells, and Immune Cells
В. В. Соболев, Ekaterina Tchepourina, I. M. Korsunskaya, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9708-9708
Open Access | Times Cited: 33

Scroll to top